Postdoctoral Research Fellowship in Pharmacoepigenetics
A full-time 3 years position as postdoctoral research fellow is available at in the research group of Professor Hedvig Nordeng and Senior Scientist Robert Lyle at the School of Pharmacy.
The postdoctoral fellow will be part of the multidisciplinary PharmaTox Strategic Research Initiative at the Faculty of Mathematics and Natural Sciences, University of Oslo.
PharmaTox is a multidisciplinary center comprising strong research environments in pharmaceutical bioscience, biology, bioinformatics and statistics.
The aim of PharmaTox is to determine the impact of specific medications on neurodevelopment and propose the molecular and cellular mechanisms involved by combining human epidemiological data with biological data and data from neurotoxicity models.
We are searching for an ambitious and highly motivated scientist with a strong interest in pharmacoepigenetics. The fellowship is for a period of three years starting 1st February 2017.
No one can be appointed for more than one fixed-term period at the same institution.
The overall aim of the project is to determine epigenetic effects of specific medications taken during pregnancy on neurodevelopment, and understand the mechanisms involved. We are looking for highly motivated candidates to focus on the role of epigenetics, particularly DNA methylation, in this process. The data consists of the Mother and Child Cohort (MoBa) at the National Institute of Public Health linked to other national health registries. The project involves both laboratory work and bioinformatics/statistical analyses. We therefore invite applications with backgrounds from these fields. The post doctoral research fellow will also be offered access to Robert Lyle's research group at the Department of Medical Genetics, Oslo University Hospital who offers an excellent research infrastructure with very well equipped facilities.
The Faculty of Mathematics and Natural Sciences has a strategic ambition of being a leading research faculty. Candidates for these fellowships will be selected in accordance with this, and expected to be in the upper segment of their class with respect to academic credentials.
Applicants must hold a PhD degree or other corresponding education equivalent to a Norwegian doctoral degree with epigenetics. The preferred candidate has research experience with large birth cohorts and health registries. Interest and experience with interdisciplinary work, public dissemination and knowledge about the Norwegian health care system is an advantage.
The research fellow should be able to work independently and structured, while at the same time engage in close collaborations.
We offer broad training possibilities within a stimulating academic environment. We also offer overseas research collaboration with possibilities to spend up to 6 months during the post doc abroad.
When evaluating the applications, emphasis will be given to their academic and personal abilities to carry out the project. Applicants may be called for an interview.
The main purpose of postdoctoral research fellowships is to qualify researchers for work in top academic positions within their disciplines.
Position code 1352, Salary: NOK 486 100 – 567 100 per year, depending on qualifications and seniority).
The application must include:
- Application letter
- Project description
- CV (summarizing education, positions, pedagogical experience, administrative experience and other qualifying activity)
- Copies of educational certificates, transcript of records and letters of recommendation
- A complete list of publications and up to 5 academic works that the applicant wishes to be considered by the evaluation committee
- Names and contact details of 2-3 references (name, relation to candidate, e-mail and telephone number)
Please remember that all documents should be in English or a Scandinavian language.
In accordance with the University of Oslo's equal opportunities policy, we invite applications from all interested individuals regardless of gender or ethnicity.
To APPLY click "Further official information" below.
This opportunity has expired. It was originally published here: